Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver disease worldwide, it causes chronic hepatitis, which leads to cirrhosis and hepatocellular carcinoma. We aimed to assess the value of liver fatty acid binding protein (L-FABP) in the diagnosis of non-alcoholic fatty liver disease in comparison to ultrasonography. Patients and Methods: Ninty subjects were enrolled in this study who attended the Hepatology, Gastroenterology and Internal medicine clinics in Benha University Hospitals between January 2017 and January 2018 and divided into group I included 70 consecutive patients with non-alcoholic fatty liver disease who were diagnosed by ultrasound with or without elevated liver enzymes and group П included 20 healthy control subjects without NAFLD (by ultrasound) with normal liver enzymes. Serum levels of L-FABP were determined by enzyme-linked immunosorbent assay. Results: NAFLD patients were slightly older than healthy subjects as mean age in group І was (37.74 ± 11.7) while in group П was (36.5 ± 11.31). There was a slight increase in NAFLD in males, there was a high prevalence of NAFLD in the urban population. L-FABP levels in NAFLD patients were higher than in the control group (levels were 188.6 ± 34.94 and 137.7 ± 13.05 ng/l respectively). A strong correlation was found between L-FABP and ALT, AST, BMI and glucose levels. Analysis of ROC curve revealed that at a level 151.1 ng/sensitivity, specificity, PPV, NPV and accuracy were 83.3%, 71.8%, 31.3%, 96.6% and 73.3% respectively with AUC 0.839 and at a level 189.5 ng/sensitivity, specificity, PPV, NPV and accuracy were 90%, Open Journal of Gastroenterology 90%, 95.4%, 95.4%, 88.9% with AUC was 0.950. Conclusion: Serum L-FABP could be used as a new diagnostic biomarker for detecting NAFLD.
Introduction
NAFLD is one of the most important causes of liver disease worldwide and will probably emerge as the leading cause of end-stage liver disease in the coming decade [1] . It encompasses a wide spectrum of histological and clinical manifestations, ranging from simple steatosis to steatohepatitis, fibrosis and cirrhosis [2] .
The global prevalence of NAFLD is currently estimated to be 24 [3] . But the highest rates are reported from South America (31%) and the Middle East (32%), followed by Asia (27%), the USA (24%) and Europe (23%), whereas NAFLD is less common in Africa (14%) [3] . Fatty acid-binding proteins (FABPs) are a family of small and highly conserved lipid chaperone molecules with highly varied functions [1] . Different members of the FABP family exhibit unique patterns of tissue expression and are expressed most abundantly in tissues involved in active lipid metabolism in hepatocytes, adipocytes and cardiac myocytes, where fatty acids are prominent substrates for lipid biosynthesis, storage or breakdown, the respective FABPs make up between 1% and 5% of all soluble cytosolic proteins [4] . In the hepatic lobule, L-FABP is expressed in hepatocytes in a declining gradient from portal to central location [5] . In addition, epithelial cells of the proximal tubules in kidneys express L-FABP mRNA [6] . A previous study has shown L-FABP to be a promising biochemical marker for the early detection of hepatocellular injury in a small group of liver transplant patients [7] . It was reported that urinary excretions of L-FABP are increased in patients with chronic hepatitis [8] . Liver type FABP (L-FABP), significantly expressed in hepatocytes, enterocytes and to a lesser degree in renal tubular cells [9] . L-FABP is a protein involved in multiple biologic functions, such as intracellular fatty acid transport, cholesterol and phospholopid metabolism, which plays an important facilitative role in hepatic fatty acid oxidation [10] . Also, Ultrasonography TOSHIBA SSA-700A (Apilo 5) was performed to assess the liver condition including NAFLD according to [11] . as follows:
Material and Methods
Grade 1: The echogenicity of the liver is just increased.
Grade 2: When the echogenic liver obscures the echogenic walls of portal vein branches.
Grade 3: When the echogenic liver obscures the diaphragmatic outline.
Statistical Analysis
The analysis of the data was carried out using SPSS (SPSS Inc., Chicago, ILL Kruskal Wallis test (KW) for non-parametric ones. Significant ANOVA and KW tests were followed by post hoc multiple comparisons using Bonferroni tests to detect the significant pairs. Correlations between L-FABP and the studied variables were assessed by Spearman's correlation coefficient (rho). ROC curves were constructed to determine cutoff values of L-FABP in the prediction of fatty liver and its grades. The accepted level of significance in this work was stated at 0.05 (P < 0.05 was considered significant). P value > 0.05 is non-significant (NS) P < 0.05 is significant (S) P ≤ 0.001 is highly significant (HS) Positive predictive value is the probability of patients with positive test results who are correctly diagnosed. Negative predictive value is the proportion of patients with negative test results who are correctly diagnosed.
Results
This study included 70 consecutive patients with NAFLD and 20 apparently healthy subjects. The epidemiologic characteristics and laboratory parameters of the two groups were summarized in Table 1 . The mean age of NAFLD patients was 37.74 ± 11.7 years while in healthy control subjects was 36.5 ± 11.31 with no statistical significant difference between the two groups. There was female predominance among both groups with no statistical significance difference. Concerning the residence, either rural or urban, 64.29% of group (І) cases had urban residence in comparison with a group (П) which was 35% urban residence and this was statistically significant (p < 0.01).
As regard BMI, there was a significant statistical difference between group I and group II concerning height, weight and BMI with mean value (171.5 ± 8.3), (84.5 ± 9.5), (28.76 ± 4.3) in group І and (177.6 ± 6.67), (74.65 ± 7.44), (23.72 ± 3.04) in group II respectively ( Table 1) .
As regard biochemical and molecular parameters: There was a highly statistically significant difference between studied groups as regard total cholesterol, TG, HDL and LDL (p < 0.001). Also there was a statistical significant difference between studied groups as regard AST, ALT and FBS (p < 0.04, p < 0.03 and P < 0.03 respectively). Also, there was a highly statistically significant difference between studied groups as regard L-FABP (P < 0.001) that was increased in group I more than in group II (Table 1 ). There was increase in levels of L-FABP in serum of NAFLD patients in relation to grades of fatty liver by ultrasound as mean levels of L-FABP (177.6 ± 26.0) corresponds to grade І fatty liver, mean levels of (189.4 ± 29.2) corresponds to grade П fatty liver and mean levels of (220.5 ± 48.5) corresponds to grade Ш fatty liver and this was clinically and statistically significant (p < 0.001) ( Table 2 and Figure 1 ). Also, there was a good positive correlation between grades of fatty liver by ultrasound and serum levels of L-FABP and this was statistically significant (p = 0.002) ( Table 3 and Figure 2 ). respectively and this was highly statistically significant (p < 0.001) ( Table 4 and Kappa test = 0.70) and this was statistically significant (p < 0.05) (Table 5 ). Also, the degree of agreement between U/S and serum L-FABP in the detection of grade III NAFLD was 72.8% (Cohen Kappa test = 0.461) and this was statistically significant (p < 0.05) ( Table 6 ).
Discussion
NAFLD is one of the most prevalent causes of chronic liver disease worldwide [3] . And represents a spectrum of diseases with some patients developing cirrhosis and hepatocellular carcinoma (HCC)) [2] . A large number of patients with NAFLD with potential for progressive liver disease creates challenges for screening, as the diagnosis of NASH necessitates invasive liver biopsy [3] . L-FABP has a low molecular weight and is present in liver cells [7] . The properties of L-FABP lead to its elevation even with a small amount of cell injury. Since hepatocytes are in direct contact with the blood and have no interstitial barrier, small proteins appear sooner in the circulation than large proteins. For these reasons, L-FABP could be a promising biochemical marker for early detection of liver cell injury [7] . The aim of this study was to assess the diagnostic value of L-FABP in Cohen Kappa test = 0.461, P < 0.001 (HS), Degree of agreement = 72.8%. Open Journal of Gastroenterology detection of NAFLD in comparison to ultrasound. In the current study, NAFLD patients were slightly older than healthy subjects as mean age in group І was (37.74 ± 11.7) while in group П was (36.5 ± 11.31), but this was statistically non-significant. In the present study, there was a slight increase of NAFLD in males (n = 32, 45.7%) in group І than group П (n = 8, 40%). While females were (n = 38, 54.3%) in group І and (n = 12, 60%) in group П. Sayiner et al., (2016) reported that several studies provide data to suggest a higher prevalence in males while others proposed the opposite [12] . In the current study, there was a high prevalence of NAFLD in urban population (n = 45, 64.29%) than rural ones (n = 25, 35.71%). This matches the study of Niriella et al., (2017) who reported that the urban cohort, when followed up for 7 years and subjected to ultrasonography of the liver again, showed their prevalence of NAFLD had increased dramatically to nearly 66% in that age (42 -71 years) population. The annual incidence of NAFLD in this population was 6.6% [13] . In the present study, there was a strong relationship between NAFLD and body mass index. BMI was elevated markedly in group І (28.76 ± 4.3) than group П (23.74 ± 3.04). This matched the study of Williams et al., (2011) who stated that NAFLD is strongly linked to obesity, with a reported prevalence as high as 80% in obese patients and only 16% in individuals with a normal BMI and without metabolic risk factors [14] . with NAFLD is atherogenic in nature and it is characterized by increased levels of serum triglycerides and decreased levels of HDL cholesterol [16] . In this study, AST and ALT levels were elevated in NAFLD group more than control group and this finding was in agreement with Armstrong et al. (2012) who reported that NAFLD detected by ultrasonography was the most common cause of abnormal liver biochemistry [17] . In a study done by Debmalya et al. (2015) who concluded that NAFLD was significantly associated with higher ALT and GGT. Also, he reported that diabetic subjects with NAFLD had significantly higher ALT, AST and GGT and significantly lower AST: ALT ratio in comparison with diabetic subjects without NAFLD, but there was no significant difference in ALP levels [18] . In the present study, there was a relation between NAFLD patients and elevated blood sugar levels. Diabetes mellitus was observed in 15 patients in group І (21.4%) and 0% in group П. Mean levels of fasting blood sugar was higher in group І (118.7 ± 42.9) than group П (96. 8 ± 11.9) . This matched the opinion of several authors as Leite et al., (2009) who stated that the prevalence of ultrasonographic NAFLD was 69.4% in 180 patients with T2DM [18] . Also, this was in agreement with Nascimbeni et al. (2013) who reported that NAFLD is strictly associated with metabolic risk factors especially obesity and type 2 diabetes mellitus (T2DM) [19] . In the current study, L-FABP levels were positively Open Journal of Gastroenterology correlated with BMI (r = 0.289, p = 0.015), AST (r = 0.350, p = 0.003), ALT (r = 0.291, p = 0.015), total cholesterol (r = 0.334, p = 0.005), triglycerides (r = 0.244, p = 0.042), and LDL (r = 0.301, p = 0.011). These findings matched with Akbal et al. (2014) who said in a similar study that L-FABP levels were positively correlated with BMI, glucose, AST, ALT and GGT levels [20] . The current study revealed statistically significant elevation in serum concentration of L-FABP levels in NAFLD group (group І) which was (188.6 ± 34.94) more than control group (group П) which was (137.7 ± 13.05). This was in agreement with Akbal et al., (2014) who reported that serum L-FABP levels were elevated in NAFLD patients [20] . In the present study, Roc curve analysis of L-FABP as a diagnostic test of NAFLD suggested that at the cut off value 151.1 ng/L (that differentiate NAFLD from healthy group) the sensitivity, specificity, Positive and negative predictive values were 83.3%, 71.8%, 31.3% and 96.6% respectively with AUC was 0.834, but at the cut off value 189.5ng/L the sensitivity, specificity, positive and negative predictive values were 90%, 85%, 95.4% and 70.8% respectively with AUC was 0.950. So, in NAFLD pateints, increased serum levels of L-FABP increases the diagnostic accuracy(at the cut off value 151.1 ng/L diagnostic accuracy was 73.3% and at the cut off value 189.5 ng/L diagnostic accuracy was 88.9%). This was in agreement with Akbal et al., (2014) who reported that to differentiate NAFLD from healthy controls, the cut-off value was 222.54 ng/mL for L-FABP (80% sensitivity and 80% specificity), positive and negative predictive values of L-FABP were 82% and 81%, respectively and when the cut-off value was 284 ng/mL, L-FABP had 73% sensitivity and 100% specificity, Positive and negative predictive values for L-FABP were 100% and 79%, respectively [20] . In the current study, there was a relation between levels of L-FABP in serum of NAFLD patients and grades of fatty liver by ultrasound as mean levels of L-FABP (177.6 ± 26.0) corresponded to grade І fatty liver, mean levels of (189.4 ± 29.2) corresponded to grade П fatty liver, mean levels of (220.5 ± 48.5) corresponded to grade Ш fatty liver and this was clinically and statistically significant (p < 0.001). Also, there was a good positive correlation between grades of fatty liver by ultrasound and serum levels of L-FABP and this was statistically significant (p = 0.002). As regards to concordance correlation coefficient between serum L-FABP and ultrasound in detection of NAFLD patients was 88.9% (by cohen kappa test = 0.70) and this was statistically significant (p < 0.001 HS). This means that there is a good degree of agreement between U/S and L-FABP in detection of NAFLD patients. Also, the concordance correlation coefficient between serum L-FABP and ultrasound in detection of grade Ш of NAFLD was 72.8% (by cohen kappa test = 0.461) and this was statistically significant (p < 0.001).
Conclusion
Liver fatty acid binding protein is a promising biomarker for early detection of liver injury in NAFLD when suspected by ultrasound and its levels correspond to the degree of fatty infiltration in liver tissue.
